Metlife earnings release, August 5, 2026

Metlife Inc (MET) · Form 8-K, Item 2.02 · Filed · SEC filing

Page 1 of 25

For Immediate Release | Global Communications | MetLife, Inc.

MetLife Announces 2Q 2026 Results

Strong business momentum continues under New Frontier strategy

• Net income increased

1%¹ to

$705 million, or

$1.09 per share.

• Adjusted earnings increased

15% to

$1.6 billion, driven by favorable underwriting and volume growth.

• Adjusted earnings per share increased

20% to

$2.43.

• Premiums, fees and other revenues (PFOs) increased

7% to

$13.7 billion.

• Adjusted PFOs, excluding pension risk transfers

(PRT), increased

5% to

$13.0 billion, with widespread growth across every operating segment.

• Net investment income up

18% to

$6.7 billion.

• Book value per share (BVPS) up

8% to

$38.59, adjusted BVPS up

3% to

$57.71.

• Returned over

$1.1 billion to sh areholders via share repurchases and common stock dividends.

• Holding company cash and liquid assets totaled

$3.4 billion at quarter end, within our target range.

• Adjusted return on equity of

17% for the second s traight quarter, at the top of our range.

• Group Benefits adjusted earnings up

25% to

$503 million.

• Retirement and Income Solutions adjusted earnings up

2% to

$377 million.

• Asia adjusted earnings up

21% to

$420 million.

• Latin America adjusted earnings up

15% to

$268 million.

• EMEA adjusted earnings up

8% to

$108 million.

• MetLife Investment Management adjusted earnings up

6% to

$57 million.

Earnings

Per Share

2Q 2026

Net

Income

$1.09

Adjusted

Earnings

$2.43

Return on Equity (ROE)

2Q 2026

ROE

11.5%

Adjusted

ROE

17.0%

Comment from Michel Khalaf, President and Chief Executive Officer:

MetLife delivered an excellent second quarter. Adjusted earnings per share rose

20 percent, powered by strong underwriting and broad volume growth.

Our New Frontier strategy is working.

Disciplined execution is driving balanced growth and generating attractive returns, with adjusted return on equity at 17 percent year-to-date.

Our scale, diversification and financial strength set MetLife apart, and this quarter further reinforces our ability to create value for shareholders across cycles, while keeping customers at the center of everything we do.¹

In this news release, all comparisons of results for the second quarter of 2026 are with the second quarter of 2025, unless otherwise noted.

Page 2 of 25

Second Quarter

2026

Summary

Information regarding the non-GAAP and other financial measures included in this news release and reconciliation of the non-GAAP financial measures to GAAP measures are in “Non-GAAP and Other Financial Disclosures” below and in the tables that accompany this news release.

Supplemental slides for the second quarter of

2026, titled “

2Q26

Earnings Call Presentation,” are available on the MetLife Investor Relations website at https://investor.metlife.com and in the

Form 8-K furnished by MetLife to the U.S. Securities and Exchange Commission in connection with this earnings release. Supplemental information about MetLife's diversified global investment portfolio is contained in the "

2Q26

- General Account Assets Under Management

Fact Sheet," available on the above-mentioned website.

Page 3 of 25

Total Company Discussion

Premiums, fees and other income were

$13.7 billion, up

7 percent compared with the prior- year quarter. Adjusted premiums, fees and other revenues, excluding pension risk transfers, were

$13.0 billion, up

5 percent.

Net investment income was

$6.7 billion, up

18 percent, primarily due to increases in the estimated fair value of certain securities that do not qualify as separate accounts under GAAP.

Adjusted net investment income was

$5.6 billion, up

7 percent, reflecting asset growth and investing in a higher-rate environment.

Net investment losses were

$338 million after tax, reflecting normal trading activity and a stable credit environment. Net derivative losses amounted to $

610 million after tax, driven by stronger equity markets, higher long-term interest rates, and strengthening of the U.S. dollar.

Net income was

$705 million, reflecting higher adjusted earnings, partially offset by certain investment-related items. On a per-share basis, net income increased

6 percent to

$1.09.

Adjusted earnings were

$1.6 billion, up

15 percent on a reported basis and

14 percent on a constant currency basis, driven by favorable underwriting and broad-based volume growth. On a per-share basis, adjusted earnings were

$2.43, up

20 percent.

Direct expense ratio, excluding total notable items related to direct expenses and PRT, was

12.1 percent, compared to

11.7 percent in the prior-year quarter, and on track for our yearly target.

Page 4 of 25

Adjusted Earnings by Segment Summary

Business Discussions

GROUP BENEFITS

• Adjusted earnings were

$503 million, up

25 percent, reflecting favorable underwriting and volume growth.

• Adjusted PFOs were

$6.5 billion, up

1 percent.

• Adjusted PFOs, excluding participating contracts, were

$5.1 billion, up

4 percent, reflecting solid growth across both N ational Accounts and Regional Business.

• Sales were up 9 percent year-to-date.

RIS

• Adjusted earnings were

$377 million, up

2 percent, driven by favorable recurring interest margins and volume growth, partially offset by lower variable investment income (VII).

• Adjusted PFOs were

$1.8 billion.

• Adjusted PFOs, excluding PRT, were

$1.3 billion, up

19 percent, mainly driven by U.K. longevity reinsurance and structured settlement sales.

• Total retained liability exposure grew

3 percent, including

2 percent in retained general account liabilities.

Page 5 of 25

ASIA

• Adjusted earnings were

$420 million, up

21 percent on a reported basis and up

25 percent... constant currency basis, driven by stronger equity markets, higher VII, and volume growth.

• Adjusted PFOs were

$1.7 billion, essentially flat on a reported basis, and up

6 percent on a constant currency basis.

• Asia general account assets under management (at amortized cost) were

$141.2 billion, up

6 percent on a constant currency basis.

• Sales were

$794 million, up

17 percent on a constant currency basis, driven by strong performance across the region.

LATIN AMERICA

• Adjusted earnings were

$268 million, up

15 percent on a reported basis and up

4 percent on a constant currency basis, driven by volume growth across the region, as well as favorable market factors, including e ncaje returns, and taxes, partially offset by the impact of the Mexico value-added tax change.

• Adjusted PFOs were

$1.9 billion, up

16 percent on a reported basis and up

6 percent on a co nstant currency basis, due to strong growth and solid persistency across the region.

• Sales were

$456 million, up

9 percent on a constant currency bas is, primarily driven by strong growth in third-party distribution across the region, particularly in Brazil, powered by our Xcelerator platform.

EMEA

• Adjusted earnings were

$108 million, up

8 percent on a reported basis and up

11 percent on a constant currency basis, driven by strong volume growth, partially offset by higher expenses.

• Adjusted PFOs were

$806 million, up

12 percent on both a reported and constant currency basis, with strong sales momentum and solid renewal activity across the region.

Page 6 of 25

• Sales were

$346 million, up

15 percent on a constant currency basis, reflecting continued broad-based growth.

METLIFE INVESTMENT MANAGEMENT

• Adjusted earnings were

$57 million, up

6 percent, driven by business growth and expense management.

• Other revenues were

$317 million, up

34 percent, primarily reflecting the acquisition of

PineBridge Investments and business growth.

• Total assets under management were

$748.1 billion, up

20 percent.

CORPORATE & OTHER

• Adjusted loss of

$160 million, compared to an adjusted loss of

$142 million.

INVESTMENTS

• Adjusted net investment income was

$5.6 billion, up

7 percent.

VII increased

18 percent to

$231 million.

SECOND QUARTER

2026 NOTABLE ITEMS

Page 7 of 25

Contacts:

For Media:

Steve LaMarca (646) 884-3840, Steve.LaMarca@metlife.com

For Investors:

John Hall (212) 578-7888, John.A.Hall@metlife.com

About MetLife

MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates (“MetLife”), is one of the world’s leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institutional customers build a more confident future. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Asia, Latin America, Europe and the Middle East. For more information, visit www.metlife.com.

Conference Call

MetLife will hold its second quarter 2026 earnings conference call on Thursday, August 6, 2026, from 9-10 a.m. (ET) via a live webcast. Please click on the following link to register: https:// events.q4inc.com/attendee/539596169. A replay of the webcast will be available at investor.metlife.com for seven days following the call.

###

Page 8 of 25

Non-GAAP and Other Financial Disclosures

In this news release, MetLife presents certain measures of its performance on a consolidated and segment basis that are not calculated in accordance with accounting principles generally accepted in the

United States of America (GAAP). MetLife believes that these non-GAAP financial measures enhance our investors’ understanding of MetLife’s performance by highlighting the results of operations and the underlying profitability drivers of the business. Segment-specific financial measures are calculated using only the portion of consolidated results attributable to that specific segment.

The following non-GAAP financial measures should not be viewed as substitutes for the most directly comparable financial measures calculated in accordance with GAAP:

Page 9 of 25

Reconciliations of these non-GAAP measures to the most directly comparable GAAP measures are not accessible on a forward-looking basis because we believe it is not possible without unreasonable effort to provide other than a range of net investment gains and losses and net derivative gains and losses, which can fluctuate significantly within or outside the range and from period to period and may have a material impact on net income (loss).

Any financial measures shown on a constant currency basis reflect the impact of changes in foreign currency exchange rates and are calculated using the average foreign currency exchange rates for the current period and applied to the comparable prior period (“constant currency basis”).

Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures are included in this earnings news release and in this period’s earnings materials, which are available at MetLife’s Investor Relations webpage (https://investor.metlife.com).

MetLife’s definitions of non-GAAP and other financial measures discussed in this news release may differ from those used by other companies:

Page 10 of 25

Adjusted earnings and related measures

• adjusted earnings;

• adjusted earnings available to common shareholders;

• adjusted earnings available to common shareholders, on a constant currency basis;

• adjusted earnings available to common shareholders, excluding total notable items;

• adjusted earnings available to common shareholders, excluding total notable items, on a constant currency basis;

• adjusted earnings available to common shareholders per diluted common share;

• ... (truncated)lders, on a constant currency basis per diluted common share;

• adjusted earnings available to common shareholders, excluding total notable items per diluted common share; and

• adjusted earnings available to common shareholders, excluding total notable items, on a constant currency basis per diluted common share.

Adjusted earnings is used by MetLife’s chief operating decision maker, its chief executive officer, to evaluate performance and allocate resources. Consistent with GAAP guidance for segment reporting, adjusted earnings is MetLife’s GAAP measure of segment performance. Adjusted earnings and related measures based on adjusted earnings are also the measures by which senior management’s and many other employees’ performance is evaluated for the purposes of determining their compensation under applicable compensation plans. Adjusted earnings and related measures based on adjusted earnings allow analysis of MetLife’s performance relative to its business plan and facilitate comparisons to industry results.

Adjusted earnings is defined as adjusted revenues less adjusted expenses, net of income tax. Adjusted earnings available to common shareholders is defined as adjusted earnings less preferred stock dividends.

Adjusted earnings, along with the related adjusted revenues, adjusted expenses and adjusted premiums, fees and other revenues, focus on our primary businesses principally by excluding the impact of (i) market volatility which could distort trends, (ii) asymmetrical and non-economic accounting, (iii) revenues and costs related to divested businesses, and (iv) other adjustments. Also, adjusted earnings and related measures exclude results of discontinued operations under GAAP.

Market volatility can have a significant impact on MetLife’s financial results. Adjusted earnings excludes net investment gains (losses), net derivative gains (losses), market risk benefit remeasurement gains

(losses) and goodwill impairments. Further, net investment income is adjusted to exclude similar items relating to joint ventures accounted for under the equity method (“Joint venture adjustments”), and policyholder benefits and claims exclude (i) changes in the discount rate on certain annuitization guarantees accounted for as additional liabilities and (ii) market value adjustments.

Asymmetrical and non-economic accounting adjustments are made in calculating adjusted earnings:

• Universal life and investment-type product policy fees exclude asymmetrical accounting associated with in-force reinsurance.

• Net investment income includes earned income on derivatives and amortization of premium on derivatives that are hedges of investments or that are used to replicate certain investments, but do not qualify for hedge accounting treatment (“Investment hedge adjustments”).

• Other revenues include settlements of foreign currency earnings hedges and exclude asymmetrical accounting associated with in-force reinsurance.

• Policyholder benefits and claims excludes (i) inflation-indexed benefit adjustments associated with contracts backed by inflation-indexed investments, (ii) asymmetrical accounting associated with in- force reinsurance, and (iii) non-economic losses incurred at contract inception for certain single premium annuity business. These losses are amortized into adjusted earnings within policyholder benefits and claims over the estimated lives of the contracts.

Page 11 of 25

• Policyholder liability remeasurement gains (losses) excludes asymmetrical accounting associated with in-force reinsurance.

• Interest credited to policyholder account balances excludes amounts associated with periodic crediting rate adjustments based on the total return of a contractually referenced pool of assets and other pass-through adjustments and asymmetrical accounting associated with in-force reinsurance.

“Divested businesses” are those that have been or will be sold or exited by MetLife but do not meet the discontinued operations criteria under GAAP. Divested businesses also include the net impact of transactions with exited businesses that have been eliminated in consolidation under GAAP and costs relating to businesses that have been or will be sold or exited by MetLife that do not meet the criteria to be included in results of discontinued operations under GAAP.

Other adjustments are made in calculating adjusted earnings:

• Beginning in the fourth quarter of 2025, net investment income excludes depreciation of wholly- owned real estate and real estate joint ventures.

• Net investment income and interest credited to policyholder account balances exclude certain amounts related to contractholder-directed equity securities (“Unit-linked contract income” and

“Unit-linked contract costs”).

• Net investment income and other expenses exclude Reinsurance activity (as defined below).

• Net investment income and interest expense on debt exclude amounts related to collateralized financing entities that are consolidated variable interest entities (“Consolidated collateralized financing entities”).

• Other revenues and other expenses exclude asset management distribution fees on funds that are passed through to distribution partners.

• Other revenues include fee revenue on synthetic guaranteed interest contracts (“GICs”) accounted for as freestanding derivatives.

• Other expenses exclude (i) amortization and impairment of asset management intangible assets,

(ii) implementation of new insurance regulatory requirements and other costs, and (iii) acquisition, integration and other related costs. Other expenses include (i) deductions for net income (loss) attributable to noncontrolling interests and redeemable noncontrolling interests, and (ii) benefits accrued on synthetic GICs accounted for as freestanding derivatives.

• “Reinsurance activity” relates to amounts subject to ceded reinsurance arrangements with third... (truncated)entures, including (i) the related investment returns and expenses which are passed through to the reinsurers and (ii) the corresponding invested assets and cash and cash equivalents.

Adjusted earnings also excludes the recognition of certain contingent assets and liabilities that could not be recognized at acquisition or adjusted for during the measurement period under GAAP business combination accounting guidance.

The tax impact of the adjustments mentioned above is calculated net of the U.S. or foreign statutory tax rate, which could differ from MetLife’s effective tax rate. Additionally, the provision for income tax

(expense) benefit also includes the impact related to the timing of certain tax credits, as well as certain tax reforms.

In addition, adjusted earnings available to common shareholders excludes the impact of preferred stock redemption premium, which is reported as a reduction to net income (loss) available to MetLife, Inc.’s common shareholders.

Investment portfolio gains (losses) and derivative gains (losses)

These are measures of investment and hedging activity. Investment portfolio gains (losses) principally excludes amounts that are reported within net investment gains (losses) but do not relate to the

Page 12 of 25 performance of the investment portfolio, such as gains (losses) on sales and divestitures of businesses, as well as investment portfolio gains (losses) of divested businesses. Derivative gains (losses) principally excludes earned income on derivatives and amortization of premium on derivatives, where such derivatives are either hedges of investments or are used to replicate certain investments, and where such derivatives do not qualify for hedge accounting. This earned income and amortization of premium is reported within adjusted earnings and not within derivative gains (losses).

Return on equity and related measures

• Total MetLife, Inc.’s adjusted common stockholders’ equity

: total MetLife, Inc.’s common stockholders’ equity, excluding unrealized investment gains (losses), net of related offsets, deferred gains (losses) on derivatives, future policy benefits discount rate remeasurement gains (losses), market risk benefits instrument-specific credit risk remeasurement gains (losses), defined benefit plans adjustment components of accumulated other comprehensive income (loss) (“AOCI”) and the embedded derivatives related to funds withheld on ceded reinsurance (representing unrealized investment gains (losses) passed through to reinsurers), all net of income tax.

• Total MetLife, Inc.’s adjusted common stockholders’ equity, excluding total notable items

: total

MetLife, Inc.’s common stockholders’ equity, excluding unrealized investment gains (losses), net of related offsets, deferred gains (losses) on derivatives, future policy benefits discount rate remeasurement gains (losses), market risk benefits instrument-specific credit risk remeasurement gains (losses), defined benefit plans adjustment components of AOCI, the embedded derivatives related to funds withheld on ceded reinsurance (representing unrealized investment gains (losses) passed through to reinsurers) and total notable items, all net of income tax.

• Return on MetLife, Inc.’s common stockholders’ equity

: net income (loss) available to MetLife, Inc.’s common shareholders divided by MetLife, Inc.’s average common stockholders’ equity.

• Adjusted return on MetLife, Inc.’s common stockholders’ equity

: adjusted earnings available to common shareholders divided by MetLife, Inc.’s average adjusted common stockholders’ equity.

• Adjusted return on MetLife, Inc.’s common stockholders’ equity, excluding total notable items

: adjusted earnings available to common shareholders, excluding total notable items, divided by

MetLife, Inc.’s average adjusted common stockholders’ equity, excluding total notable items.

The above measures represent a level of equity that excludes most components of AOCI, such as unrealized investment gains (losses), net of related offsets, and future policy benefits discount rate remeasurement gains (losses), as well as the impact of certain ceded reinsurance-related embedded derivatives, as these amounts are primarily driven by market volatility.

Expense ratio, direct expense ratio, adjusted expense ratio and related measures

• Expense ratio

: other expenses, net of capitalization of DAC, divided by premiums, fees and other revenues.

• Direct expense ratio

: direct expenses divided by adjusted premiums, fees and other revenues. Direct expenses are comprised of employee-related costs, third-party staffing costs, and general and administrative expenses.

• Direct expense ratio, excluding total notable items related to direct expenses and PRT

: direct expenses, excluding total notable items related to direct expenses, divided by adjusted premiums, fees and other revenues, excluding PRT.

• Adjusted expense ratio

: adjusted other expenses, net of adjusted capitalization of DAC, divided by adjusted premiums, fees and other revenues.

• Adjusted expense ratio, excluding total notable items related to adjusted other expenses and PRT

: adjusted other expenses, net of adjusted capitalization of DAC, excluding total notable items related to adjusted other expenses, divided by adjusted premiums, fees and other revenues, excluding PRT.

Page 13 of 25

Assets Under Management (

“

AUM”)

• Total Assets Under Management (“Total AUM”) is comprised of MIM GA AUM plus Institutional Client

AUM (each, as defined below).

• MIM General Account AUM (“MIM GA AUM”) is used by MetLife to describe the portion of GA AUM

(as defined below) that MetLife Investment Management, LLC and certain of its affiliates (“MIM”) manages or advises.

• General Account AUM (“GA AUM”) is used by MetLife to describe assets in its general account... (truncated)ed of GA total investments, the portion of the GA investment portfolio classified within assets held-for-sale, cash and cash equivalents, and accrued investment income on such assets, and excludes policy loans, certain contractholder-directed equity securities, fair value option securities, mortgage loans originated for third parties, assets subject to ceded reinsurance arrangements with third parties and joint ventures, and certain other invested assets. Mortgage loans and real estate and real estate joint ventures included in GA AUM (at net asset value, net of deduction for encumbering debt) have been adjusted from carrying value to estimated fair value. Classification of GA AUM by sector is based on the nature and characteristics of the underlying investments which can vary from how they are classified under GAAP. Accordingly, the underlying investments within certain real estate and real estate joint ventures that are primarily commercial mortgage loans (at net asset value, net of deduction for encumbering debt) have been reclassified to exclude them from real estate and real estate joint ventures and include them as commercial mortgage loans.

• Institutional Client AUM is comprised of SA AUM plus Reinsurance AUM plus TP AUM (each, as defined below). MIM manages or advises Institutional Client AUM in accordance with client guidelines contained in each investment advisory agreement.

◦ Separate Account AUM (“SA AUM”) is comprised of separate account investment portfolios, which are managed or advised by MIM and included in MetLife, Inc.’s consolidated financial statements at estimated fair value, as well as accrued investment income on such assets.

◦ Reinsurance AUM is comprised of GA assets subject to ceded reinsurance arrangements with third parties and joint ventures, which are managed or advised by MIM and are generally included in MetLife, Inc.’s consolidated financial statements at estimated fair value, as well as accrued investment income on such assets.

◦ Third-Party AUM (“TP AUM”) is comprised of non-proprietary assets managed or advised by MIM on behalf of unaffiliated/third-party clients, which are stated at estimated fair value, as well as accrued investment income on such assets. Such non-proprietary assets are owned by unaffiliated/third-party clients and, accordingly, are generally not included in MetLife, Inc.’s consolidated financial statements.

• Asia General Account AUM (“Asia GA AUM”) is used by MetLife to describe assets in its Asia GA investment portfolio. Asia GA AUM is stated at estimated fair value and is comprised of Asia GA total investments, the portion of the Asia GA investment portfolio classified within assets held-for-sale, cash and cash equivalents, and accrued investment income on such assets, and excludes policy loans, certain contractholder-directed equity securities, fair value option securities, mortgage loans originated for third parties, assets subject to ceded reinsurance arrangements with third parties and joint ventures, and certain other invested assets. Mortgage loans and real estate and real estate joint ventures included in Asia GA AUM (at net asset value, net of deduction for encumbering debt) have been adjusted from carrying value to estimated fair value. At the segment level, intersegment balances (intercompany activity, primarily related to investments in subsidiaries that eliminate at the

MetLife consolidated level) are excluded from Asia GA AUM.

Asia GA AUM (at amortized cost) excludes the following adjustments: (i) unrealized gain (loss) on investments carried at estimated fair value and (ii) adjustments from carrying value to estimated fair value on mortgage loans and real estate and real estate joint ventures. Asia GA AUM (at amortized

Page 14 of 25 cost) is presented net of related allowance for credit loss.

Other items

The following additional information is relevant to an understanding of MetLife’s performance:

• Statistical sales information:

• Group Benefits: calculated using 10% of single premium deposits and 100% of annualized full- year premiums and fees from recurring premium policy sales of all products.

• RIS: calculated using 10% of single premium contracts, on and off-balance sheet deposits, and the contract value for new U.K. longevity reinsurance contracts, and 100% of annualized full-year premiums and fees only from recurring premium policy sales of specialized benefit resources and corporate-owned life insurance.

• Asia, Latin America and EMEA: calculated using 10% of single premium deposits (mainly from retirement products such as variable annuity, fixed annuity and pensions), 20% of single premium deposits from credit insurance and 100% of annualized full-year premiums and fees from recurring-premium policy sales of all products (mainly from risk and protection products such as individual life, accident & health and group).

Sales statistics do not correspond to revenues under GAAP, but are used as relevant measures of business activity.

• Volume growth, where cited, represents the change in certain measures of our segment results, including adjusted earnings, attributable to business growth, applying a model in which certain margins and factors are held constant, the most significant of which are underwriting margins, investment margins, changes in equity market performance, expense margins and the impact of changes in foreign currency exchange rates.

• PRT includes U.K. funded reinsurance.

• Institutional net flows reflect Institutional Client AUM total fund additions less withdrawals.

• “Third-party mortgage loan activity” relates to amounts associated with mortgage loans originated and acquired for third parties, including (i) the related investment returns and expenses which are passed through to the third-party lenders and (ii) the corresponding mortgage loan assets.

• ... (truncated)d curves as of a particular date in connection with making our estimates for future results. The observable forward yield curves at a given time are based on implied future interest rates along a range of interest rate durations. This includes the 10-year U.S.

Treasury rate which we use as a benchmark rate to describe longer-term interest rates used in our estimates for future results.

• Notable items reflect the unexpected impact of events that affect MetLife’s results, but that were unknown and that MetLife could not anticipate when it devised its business plan. Notable items also include certain items regardless of the extent anticipated in the business plan, to help investors have a better understanding of MetLife’s results and to evaluate and forecast those results. Notable items represent a positive (negative) impact to adjusted earnings available to common shareholders.

• Holding company cash and liquid assets are held by MetLife, Inc. collectively with other MetLife holding companies and include cash and cash equivalents, short-term investments and publicly traded securities excluding assets that are pledged or otherwise committed. Assets pledged or otherwise committed include amounts received in connection with securities lending, repurchase agreements, derivatives, regulatory deposits, the collateral financing arrangement, funding agreements and secured borrowings, as well as amounts held in the closed block.

• MetLife uses a measure of free cash flow to facilitate an understanding of its ability to generate cash for reinvestment into its businesses or use in non-mandatory capital actions. MetLife defines free cash flow as the sum of cash available at MetLife’s holding companies from dividends from operating

Page 15 of 25 subsidiaries, expenses and other net flows of the holding companies (including capital contributions to subsidiaries), and net contributions from debt to be at or below target leverage ratios. This measure of free cash flow is prior to capital actions, such as common stock dividends and repurchases, debt reduction and mergers and acquisitions. Free cash flow should not be viewed as a substitute for net cash provided by (used in) operating activities calculated in accordance with

GAAP. The free cash flow ratio is typically expressed as a percentage of annual adjusted earnings available to common shareholders.

Financial statements

Income Statement

June 30, 2026 (in millions)

For the Three Months EndedFor the Three Months EndedFor the Three Months EndedFor the Year-to-Date Period Ended
GAAP CONSOLIDATED STATEMENTS OF OPERATIONSUnaudited (In millions)June 30, 2025September 30, 2025December 31, 2025March 31, 2026June 30, 2026
RevenuesPremiums10,81010,55516,69112,12011,435
RevenuesUniversal life and investment-type product policy fees1,2591,2471,2681,3431,372
RevenuesNet investment income5,6616,0895,9245,3556,702
RevenuesOther revenues679724737852845
RevenuesNet investment gains (losses)-273-325-160-670-428
RevenuesNet derivative gains (losses)-796-929-64674-772
RevenuesTotal revenues17,34017,36123,81419,07419,154
ExpensesPolicyholder benefits and claims10,76710,36916,77611,86411,335
ExpensesPolicyholder liability remeasurement (gains) losses5-15935-1318
ExpensesMarket risk benefit remeasurement (gains) losses-277-263-267120-270
ExpensesInterest credited to policyholder account balances2,4002,5612,3421,6743,067
ExpensesPolicyholder dividends146134129124125
ExpensesAmortization of DAC, VOBA and negative VOBA528522545568588
ExpensesInterest expense on debt269271263265292
ExpensesOther expenses, net of capitalization of DAC2,5222,7162,8742,9652,964
ExpensesTotal expenses16,36016,15122,69717,56718,119
ExpensesIncome (loss) before provision for income tax9801,2101,1171,5071,035
ExpensesProvision for income tax expense (benefit)245308301345256
ExpensesNet income (loss)7359028161,162779
ExpensesLess: Net income (loss) attributable to noncontrolling interests and redeemable noncontrolling interests667-2343
ExpensesNet income (loss) attributable to MetLife, Inc.7298968091,185736
ExpensesLess: Preferred stock dividends3166314531
ExpensesPreferred stock redemption premium12
ExpensesNet income (loss) available to MetLife, Inc.'s common shareholders6988187781,140705
ExpensesPremiums, fees and other revenues12,74812,52618,69614,31513,652

Income Statement

June 30, 2026

METLIFE CORPORATE OVERVIEW – For the Three Months Ended – June 30, 2025For the Three Months EndedMETLIFE CORPORATE OVERVIEW – For the Three Months Ended – September 30, 2025For the Three Months EndedMETLIFE CORPORATE OVERVIEW – For the Three Months Ended – December 31, 2025For the Three Months EndedMETLIFE CORPORATE OVERVIEW – For the Three Months Ended – March 31, 2026For the Three Months EndedMETLIFE CORPORATE OVERVIEW – For the Three Months Ended – June 30, 2026For the Three Months Ended
Net income (loss) available to MetLife, Inc.'s common shareholders6988187781,140705
Adjustments from net income (loss) available to MetLife, Inc.'s common shareholders to adjusted earnings available to common shareholders:Less: Net investment gains (losses)-273-325-160-670-428
Adjustments from net income (loss) available to MetLife, Inc.'s common shareholders to adjusted earnings available to common shareholders:Less: Net derivative gains (losses)-796-929-64674-772
Adjustments from net income (loss) available to MetLife, Inc.'s common shareholders to adjusted earnings available to common shareholders:Less: Market risk benefit remeasurement gains (losses)277263267-120270
Adjustments from net income (loss) available to MetLife, Inc.'s common shareholders to adjusted earnings available to common shareholders:Less: Other adjustments to net income (loss) (1)-6120-51477-129
Adjustments from net income (loss) available to MetLife, Inc.'s common shareholders to adjusted earnings available to common shareholders:Less: Provision for income tax (expense) benefit195223190170234
Adjustments from net income (loss) available to MetLife, Inc.'s common shareholders to adjusted earnings available to common shareholders:Add: Net income (loss) attributable to noncontrolling interests and redeemable noncontrolling interests667-2343
Adjustments from net income (loss) available to MetLife, Inc.'s common shareholders to adjusted earnings available to common shareholders:Add: Preferred stock redemption premium12
Adjustments from net income (loss) available to MetLife, Inc.'s common shareholders to adjusted earnings available to common shareholders:Adjusted earnings available to common shareholders1,3621,5841,6481,5861,573
Adjustments from net income (loss) available to MetLife, Inc.'s common shareholders to adjusted earnings available to common shareholders:Less: Total notable items (2)18-61
Adjustments from net income (loss) available to MetLife, Inc.'s common shareholders to adjusted earnings available to common shareholders:Adjusted earnings available to common shareholders, excluding total notable items (2)1,3621,5661,7091,5861,573
Adjustments from net income (loss) available to MetLife, Inc.'s common shareholders to adjusted earnings available to common shareholders:Net income (loss) available to MetLife, Inc.'s common shareholders per diluted common share1.031.221.171.741.09

Income Statement

METLIFE KEY ADJUSTED EARNINGS STATEMENT LINE ITEMS — June 30, 2026 (in millions)

METLIFE KEY ADJUSTED EARNINGS STATEMENT LINE ITEMS – For the Three Months Ended – June 30, 2025For the Three Months EndedMETLIFE KEY ADJUSTED EARNINGS STATEMENT LINE ITEMS – For the Three Months Ended – June 30, 2025For the Three Months EndedMETLIFE KEY ADJUSTED EARNINGS STATEMENT LINE ITEMS – For the Three Months Ended – September 30, 2025For the Three Months EndedMETLIFE KEY ADJUSTED EARNINGS STATEMENT LINE ITEMS – For the Three Months Ended – September 30, 2025For the Three Months EndedMETLIFE KEY ADJUSTED EARNINGS STATEMENT LINE ITEMS – For the Three Months Ended – December 31, 2025For the Three Months EndedMETLIFE KEY ADJUSTED EARNINGS STATEMENT LINE ITEMS – For the Three Months Ended – December 31, 2025For the Three Months EndedMETLIFE KEY ADJUSTED EARNINGS STATEMENT LINE ITEMS – For the Three Months Ended – March 31, 2026For the Three Months EndedMETLIFE KEY ADJUSTED EARNINGS STATEMENT LINE ITEMS – For the Three Months Ended – March 31, 2026For the Three Months EndedMETLIFE KEY ADJUSTED EARNINGS STATEMENT LINE ITEMS – For the Three Months Ended – June 30, 2026For the Three Months EndedMETLIFE KEY ADJUSTED EARNINGS STATEMENT LINE ITEMS – For the Three Months Ended – June 30, 2026For the Three Months EndedFor the Year-to-Date Period Ended – June 30, 2025For the Year-to-Date Period EndedFor the Year-to-Date Period Ended – June 30, 2025For the Year-to-Date Period EndedFor the Year-to-Date Period Ended – June 30, 2026For the Year-to-Date Period EndedFor the Year-to-Date Period Ended – June 30, 2026For the Year-to-Date Period Ended
Total revenues17,34017,36123,81419,07419,15435,90938,228
Less: Adjustments to total revenues:Net investment gains (losses)-273-325-160-670-428-660-1,098
Less: Adjustments to total revenues:Net derivative gains (losses)-796-929-64674-772-364-698
Less: Adjustments to total revenues:Investment hedge adjustments-102-100-105-84-170-205-254
Less: Adjustments to total revenues:Depreciation of wholly-owned real estate and real estate joint ventures (1)-72-61-54-115
Less: Adjustments to total revenues:Asymmetrical and non-economic accounting, excluding Investment hedge adjustments427810013213178263
Less: Adjustments to total revenues:Joint venture adjustments16-8-641823-2641
Less: Adjustments to total revenues:Unit-linked contract income498580366-318998271680
Less: Adjustments to total revenues:Reinsurance activity4717722230133190632
Less: Adjustments to total revenues:Consolidated collateralized financing entities2323
Less: Adjustments to total revenues:Other-16-15-17-3-31-3
Less: Adjustments to total revenues:Divested businesses32-18
Less: Adjustments to total revenues:Total adjusted revenues17,92117,90124,19119,68219,07536,74838,757
Less: Adjustments to total revenues:Unaudited (In millions)June 30, 2025September 30, 2025December 31, 2025March 31, 2026June 30, 2026June 30, 2025June 30, 2026
Less: Adjustments to total revenues:Net investment income5,6616,0895,9245,3556,70210,54612,057
Less: Adjustments to net investment income:Investment hedge adjustments-102-100-105-84-170-205-254
Less: Adjustments to net investment income:Depreciation of wholly-owned real estate and real estate joint ventures (1)-72-61-54-115
Less: Adjustments to net investment income:Joint venture adjustments16-8-641823-2641
Less: Adjustments to net investment income:Unit-linked contract income498580366-318998271680
Less: Adjustments to net investment income:Reinsurance activity4717722230133190632
Less: Adjustments to net investment income:Consolidated collateralized financing entities2323
Less: Adjustments to net investment income:Divested businesses1
Less: Adjustments to net investment income:Adjusted net investment income5,2025,4405,5775,4995,55110,41511,050
Less: Adjustments to net investment income:Unaudited (In millions)June 30, 2025September 30, 2025December 31, 2025March 31, 2026June 30, 2026June 30, 2025June 30, 2026
Less: Adjustments to net investment income:Variable investment income (Included in net investment income above)195483497518231522749
Less: Adjustments to net investment income:Unaudited (In millions)June 30, 2025September 30, 2025December 31, 2025March 31, 2026June 30, 2026June 30, 2025June 30, 2026
Less: Adjustments to net investment income:Premiums, fees and other revenues12,74812,52618,69614,31513,65226,38727,967
Less: Adjustments to premiums, fees and other revenues:Asymmetrical and non-economic accounting427810013213178263
Less: Adjustments to premiums, fees and other revenues:Other-16-15-17-3-31-3
Less: Adjustments to premiums, fees and other revenues:Divested businesses32-17

Income Statement

June 30, 2026

METLIFE SUMMARY OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – June 30, 2025METLIFE SUMMARY OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – September 30, 2025METLIFE SUMMARY OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – December 31, 2025METLIFE SUMMARY OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – March 31, 2026METLIFE SUMMARY OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – June 30, 2026
Adjusted earnings before provision for income taxGROUP BENEFITS508577589555636
Adjusted earnings before provision for income taxRIS460551563558463
Adjusted earnings before provision for income taxASIA489752625689590
Adjusted earnings before provision for income taxLATIN AMERICA317208270330351
Adjusted earnings before provision for income taxEMEA128115129143133
Adjusted earnings before provision for income taxMIM7278806376
Adjusted earnings before provision for income taxCORPORATE & OTHER-141-100-86-192-155
Adjusted earnings before provision for income taxTotal adjusted earnings before provision for income tax1,8332,1812,1702,1462,094
Provision for income tax expense (benefit)GROUP BENEFITS107121124116133
Provision for income tax expense (benefit)RIS9011010910786
Provision for income tax expense (benefit)ASIA143212181202170
Provision for income tax expense (benefit)LATIN AMERICA84607210183
Provision for income tax expense (benefit)EMEA2828323325
Provision for income tax expense (benefit)MIM1820201619
Provision for income tax expense (benefit)CORPORATE & OTHER-30-20-47-60-26
Provision for income tax expense (benefit)Total provision for income tax expense (benefit)440531491515490
Adjusted earnings available to common shareholdersGROUP BENEFITS401456465439503
Adjusted earnings available to common shareholdersRIS370441454451377
Adjusted earnings available to common shareholdersASIA346540444487420
Adjusted earnings available to common shareholdersLATIN AMERICA233148198229268
Adjusted earnings available to common shareholdersEMEA1008797110108
Adjusted earnings available to common shareholdersMIM5458604757
Adjusted earnings available to common shareholdersCORPORATE & OTHER (1)-142-146-70-177-160
Adjusted earnings available to common shareholdersTotal adjusted earnings available to common shareholders (1)1,3621,5841,6481,5861,573

Income Statement

June 30, 2026

GROUP BENEFITS STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – June 30, 2025GROUP BENEFITS STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – September 30, 2025GROUP BENEFITS STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – December 31, 2025GROUP BENEFITS STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – March 31, 2026GROUP BENEFITS STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Year-to-Date Period Ended – June 30, 2026June 30, 2025June 30, 2026
Adjusted revenuesPremiums5,8015,6625,6325,8485,81911,56411,667
Adjusted revenuesUniversal life and investment-type product policy fees240227236230242473472
Adjusted revenuesNet investment income345356358352357698709
Adjusted revenuesOther revenues405417419461451839912
Adjusted revenuesTotal adjusted revenues6,7916,6626,6456,8916,86913,57413,760
Adjusted expensesPolicyholder benefits and claims and policyholder dividends5,1614,9824,8895,1475,05310,34410,200
Adjusted expensesPolicyholder liability remeasurement (gains) losses-4-9-3-2-2-22-4
Adjusted expensesInterest credited to policyholder account balances7373717069145139
Adjusted expensesCapitalization of DAC-7-7-7-6-6-12-12
Adjusted expensesAmortization of DAC, VOBA and negative VOBA7761281320
Adjusted expensesInterest expense on debt111223
Adjusted expensesOther expenses1,0521,0381,1001,1141,1092,1282,223
Adjusted expensesTotal adjusted expenses6,2836,0856,0566,3366,23312,59812,569
Adjusted expensesAdjusted earnings before provision for income tax5085775895556369761,191
Adjusted expensesProvision for income tax expense (benefit)107121124116133205249
Adjusted expensesAdjusted earnings401456465439503771942
Adjusted expensesAdjusted earnings available to common shareholders401456465439503771942
Adjusted expensesLess: Total notable items-2
Adjusted expensesAdjusted earnings available to common shareholders, excluding total notable items401458465439503771942
Adjusted expensesAdjusted premiums, fees and other revenues6,4466,3066,2876,5396,51212,87613,051

Income Statement

June 30, 2026

ASIA STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – June 30, 2025ASIA STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – September 30, 2025ASIA STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – December 31, 2025ASIA STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – March 31, 2026ASIA STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Year-to-Date Period Ended – June 30, 2026June 30, 2025June 30, 2026
Adjusted revenuesPremiums1,2781,2901,2221,2941,2372,5382,531
Adjusted revenuesUniversal life and investment-type product policy fees399407428427441805868
Adjusted revenuesNet investment income1,2041,3741,4051,4611,3752,4082,836
Adjusted revenuesOther revenues22202117203737
Adjusted revenuesTotal adjusted revenues2,9033,0913,0763,1993,0735,7886,272
Adjusted expensesPolicyholder benefits and claims and policyholder dividends1,0511,0741,0101,0881,0302,0882,118
Adjusted expensesPolicyholder liability remeasurement (gains) losses-12-1416-15-15-23-30
Adjusted expensesInterest credited to policyholder account balances7578048258338621,4681,695
Adjusted expensesCapitalization of DAC-418-435-413-465-470-769-935
Adjusted expensesAmortization of DAC, VOBA and negative VOBA223207208211214439425
Adjusted expensesOther expenses8138308158588621,5621,720
Adjusted expensesTotal adjusted expenses2,4142,3392,4512,5102,4834,7654,993
Adjusted expensesAdjusted earnings before provision for income tax4897526256895901,0231,279
Adjusted expensesProvision for income tax expense (benefit)143212181202170305372
Adjusted expensesAdjusted earnings346540444487420718907
Adjusted expensesAdjusted earnings available to common shareholders346540444487420718907
Adjusted expensesLess: Total notable items70
Adjusted expensesAdjusted earnings available to common shareholders, excluding total notable items346470444487420718907
Adjusted expensesAdjusted premiums, fees and other revenues1,6991,7171,6711,7381,6983,3803,436

Income Statement

June 30, 2026

EMEA STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – June 30, 2025EMEA STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – September 30, 2025EMEA STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – December 31, 2025EMEA STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – March 31, 2026EMEA STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Year-to-Date Period Ended – June 30, 2026June 30, 2025June 30, 2026
Adjusted revenuesPremiums6266386796896981,2081,387
Adjusted revenuesUniversal life and investment-type product policy fees8482989998162197
Adjusted revenuesNet investment income6166686767119134
Adjusted revenuesOther revenues97109101719
Adjusted revenuesTotal adjusted revenues7807938558648731,5061,737
Adjusted expensesPolicyholder benefits and claims and policyholder dividends309333334337335586672
Adjusted expensesPolicyholder liability remeasurement (gains) losses43-13-54-2
Adjusted expensesInterest credited to policyholder account balances20212521213742
Adjusted expensesCapitalization of DAC-136-151-155-155-162-262-317
Adjusted expensesAmortization of DAC, VOBA and negative VOBA888510097110182207
Adjusted expensesOther expenses367387423418441722859
Adjusted expensesTotal adjusted expenses6526787267217401,2691,461
Adjusted expensesAdjusted earnings before provision for income tax128115129143133237276
Adjusted expensesProvision for income tax expense (benefit)28283233255458
Adjusted expensesAdjusted earnings1008797110108183218
Adjusted expensesAdjusted earnings available to common shareholders1008797110108183218
Adjusted expensesLess: Total notable items-1
Adjusted expensesAdjusted earnings available to common shareholders, excluding total notable items1008897110108183218
Adjusted expensesAdjusted premiums, fees and other revenues7197277877978061,3871,603

Income Statement

June 30, 2026

MIM STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – June 30, 2025MIM STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – September 30, 2025MIM STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – December 31, 2025MIM STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – March 31, 2026MIM STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Year-to-Date Period Ended – June 30, 2026June 30, 2025June 30, 2026
Adjusted revenuesNet investment income2125237
Adjusted revenuesOther revenues237238239314317455631
Adjusted revenuesTotal adjusted revenues239239241319319458638
Adjusted expensesInterest expense on debt112
Adjusted expensesOther expenses167161161255242349497
Adjusted expensesTotal adjusted expenses167161161256243349499

Income Statement

June 30, 2026

CORPORATE & OTHER STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – June 30, 2025CORPORATE & OTHER STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – September 30, 2025CORPORATE & OTHER STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – December 31, 2025CORPORATE & OTHER STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – March 31, 2026CORPORATE & OTHER STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Year-to-Date Period Ended – June 30, 2026June 30, 2025June 30, 2026
Adjusted revenuesPremiums6326326845925961,2981,188
Adjusted revenuesUniversal life and investment-type product policy fees635537343813172
Adjusted revenuesNet investment income9791,0381,0869539441,9781,897
Adjusted revenuesOther revenues-93-91-96-118-111-180-229
Adjusted revenuesTotal adjusted revenues1,5811,6341,7111,4611,4673,2272,928
Adjusted expensesPolicyholder benefits and claims and policyholder dividends1,1711,1601,2021,1101,0632,3812,173
Adjusted expensesPolicyholder liability remeasurement (gains) losses164622333255
Adjusted expensesInterest credited to policyholder account balances35372927187145
Adjusted expensesCapitalization of DAC-4-6-8-6-3-11-9
Adjusted expensesAmortization of DAC, VOBA and negative VOBA525552494210791
Adjusted expensesInterest expense on debt260263256255264510519
Adjusted expensesOther expenses192221260196205380401
Adjusted expensesTotal adjusted expenses1,7221,7341,7971,6531,6223,4703,275
Adjusted expensesAdjusted earnings before provision for income tax-141-100-86-192-155-243-347
Adjusted expensesProvision for income tax expense (benefit)-30-20-47-60-26-69-86
Adjusted expensesAdjusted earnings-111-80-39-132-129-174-261
Adjusted expensesPreferred stock dividends31663145319776
Adjusted expensesAdjusted earnings available to common shareholders-142-146-70-177-160-271-337
Adjusted expensesLess: Total notable items13-32
Adjusted expensesAdjusted earnings available to common shareholders, excluding total notable items-142-159-38-177-160-271-337
Adjusted expensesAdjusted premiums, fees and other revenues6025966255085231,2491,031
Adjusted expensesAdjusted earnings available to common shareholders attributed to business activities115173146109129235238

Income Statement

Appendix

APPENDIX METLIFE RECONCILIATION DETAIL – For the Three Months Ended – June 30, 2025APPENDIX METLIFE RECONCILIATION DETAIL – For the Three Months Ended – September 30, 2025APPENDIX METLIFE RECONCILIATION DETAIL – For the Three Months Ended – December 31, 2025APPENDIX METLIFE RECONCILIATION DETAIL – For the Three Months Ended – March 31, 2026APPENDIX METLIFE RECONCILIATION DETAIL – For the Three Months Ended – June 30, 2026APPENDIX METLIFE RECONCILIATION DETAIL – For the Year-to-Date Period Ended – June 30, 2025APPENDIX METLIFE RECONCILIATION DETAIL – For the Year-to-Date Period Ended – June 30, 2026
Reconciliation to Adjusted Earnings Available to Common ShareholdersNet income (loss) available to MetLife, Inc.'s common shareholders6988187781,1407051,5771,845
Reconciliation to Adjusted Earnings Available to Common ShareholdersAdd: Preferred stock dividends31663145319776
Reconciliation to Adjusted Earnings Available to Common ShareholdersAdd: Preferred stock redemption premium12
Reconciliation to Adjusted Earnings Available to Common ShareholdersAdd: Net income (loss) attributable to noncontrolling interests and redeemable noncontrolling interests667-23431120
Reconciliation to Adjusted Earnings Available to Common ShareholdersNet income (loss)7359028161,1627791,6851,941
Less: adjustments from net income (loss) to adjusted earnings:Net investment gains (losses)-273-325-160-670-428-660-1,098
Less: adjustments from net income (loss) to adjusted earnings:Net derivative gains (losses)-796-929-64674-772-364-698
Less: adjustments from net income (loss) to adjusted earnings:Market risk benefit remeasurement gains (losses)277263267-120270-22150
Less: adjustments from net income (loss) to adjusted earnings:Premiums - Divested businesses317
Universal life and investment-type product policy feesAsymmetrical and non-economic accounting6252449
Net investment incomeInvestment hedge adjustments-102-100-105-84-170-205-254
Net investment incomeJoint venture adjustments16-8-641823-2641
Net investment incomeDepreciation of wholly-owned real estate and real estate joint ventures (1)-72-61-54-115

Income Statement

Three Months Ended June 30, — Summary ($ in millions, except per share data)

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025Three Months Ended June 30, – Change
Premiums, fees and other revenues13,65212,7487.0%
Net investment income6,7025,66118.0%
Net investment gains (losses)-428-273
Net derivative gains (losses)-772-796
Total revenues19,15417,340
Adjusted premiums, fees and other revenues13,52412,7196.0%
Adjusted premiums, fees and other revenues, excluding pension risk transfers (PRT)13,01412,3915.0%
Market risk benefit remeasurement gains (losses)270277
Net income (loss)7056981.0%
Net income (loss) per share1.091.036.0%
Adjusted earnings1,5731,36215.0%
Adjusted earnings per share2.432.0220.0%
Adjusted earnings, excluding total notable items1,5731,36215.0%
Adjusted earnings, excluding total notable items per share2.432.0220.0%
Book value per share38.5935.798.0%
Adjusted book value per share57.7156.233.0%
Expense ratio21.7%19.8%
Direct expense ratio, excluding total notable items related to direct expenses and PRT12.1%11.7%
Adjusted expense ratio, excluding total notable items related to adjusted other expenses and PRT20.8%19.8%
ROE11.5%11.7%
Adjusted ROE17.0%14.6%
Adjusted ROE, excluding total notable items17.0%14.6%

Income Statement

Page 17 of 25 (in millions)

MetLife, Inc. – GAAP Consolidated Statements of Operations – For the Three Months Ended – June 30, – 2026MetLife, Inc. – GAAP Consolidated Statements of Operations – For the Three Months Ended – June 30, – 2025
RevenuesPremiums11,43510,810
RevenuesUniversal life and investment-type product policy fees1,3721,259
RevenuesNet investment income6,7025,661
RevenuesOther revenues845679
RevenuesNet investment gains (losses)-428-273
RevenuesNet derivative gains (losses)-772-796
RevenuesTotal revenues19,15417,340
ExpensesPolicyholder benefits and claims11,33510,767
ExpensesPolicyholder liability remeasurement (gains) losses185
ExpensesMarket risk benefit remeasurement (gains) losses-270-277
ExpensesInterest credited to policyholder account balances3,0672,400
ExpensesPolicyholder dividends125146
ExpensesAmortization of DAC, VOBA and negative VOBA588528
ExpensesInterest expense on debt292269
ExpensesOther expenses, net of capitalization of DAC2,9642,522
ExpensesTotal expenses18,11916,360
ExpensesIncome (loss) before provision for income tax1,035980
ExpensesProvision for income tax expense (benefit)256245
ExpensesNet income (loss)779735
ExpensesLess: Net income (loss) attributable to noncontrolling interests and redeemable noncontrolling interests436
ExpensesNet income (loss) attributable to MetLife, Inc.736729
ExpensesLess: Preferred stock dividends3131
ExpensesNet income (loss) available to MetLife, Inc.'s common shareholders705698

Income Statement

Page 18 of 25 (In millions, except per share data)

MetLife, Inc. – For the Three Months Ended – June 30, – 2026MetLife, Inc. – For the Three Months Ended – June 30, – 2026 – Earnings Per Weighted Average Common Share Diluted (1)MetLife, Inc. – For the Three Months Ended – June 30, – 2025MetLife, Inc. – For the Three Months Ended – June 30, – 2025 – Earnings Per Weighted Average Common Share Diluted (1)
Net income (loss) available to MetLife, Inc.'s common shareholders7051.096981.03

Income Statement

Page 19 of 25 (in millions)

MetLife, Inc. – For the Three Months Ended – June 30, – 2026MetLife, Inc. – For the Three Months Ended – June 30, – 2025
Premiums, Fees and Other RevenuesPremiums, fees and other revenues13,65212,748
Less: Adjustments to premiums, fees and other revenues:Asymmetrical and non-economic accounting13142
Less: Adjustments to premiums, fees and other revenues:Other-3-16
Less: Adjustments to premiums, fees and other revenues:Divested businesses3
Less: Adjustments to premiums, fees and other revenues:Adjusted premiums, fees and other revenues13,52412,719
Less: Adjustments to premiums, fees and other revenues:Adjusted premiums, fees and other revenues, on a constant currency basis13,52412,776
Less: Adjustments to premiums, fees and other revenues:Less: PRT510328
Less: Adjustments to premiums, fees and other revenues:Adjusted premiums, fees and other revenues, excluding PRT, on a constant currency basis13,01412,448
Net Investment IncomeNet investment income6,7025,661
Less: Adjustments to net investment income:Investment hedge adjustments-170-102
Less: Adjustments to net investment income:Depreciation of wholly-owned real estate and real estate joint ventures-54
Less: Adjustments to net investment income:Joint venture adjustments2316
Less: Adjustments to net investment income:Unit-linked contract income998498
Less: Adjustments to net investment income:Reinsurance activity33147
Less: Adjustments to net investment income:Consolidated collateralized financing entities23
Less: Adjustments to net investment income:Adjusted net investment income5,5515,202
Revenues and ExpensesTotal revenues19,15417,340
Less: Adjustments to total revenues:Net investment gains (losses)-428-273
Less: Adjustments to total revenues:Net derivative gains (losses)-772-796
Less: Adjustments to total revenues:Investment hedge adjustments-170-102
Less: Adjustments to total revenues:Depreciation of wholly-owned real estate and real estate joint ventures-54
Less: Adjustments to total revenues:Asymmetrical and non-economic accounting, excluding Investment hedge adjustments13142
Less: Adjustments to total revenues:Joint venture adjustments2316
Less: Adjustments to total revenues:Unit-linked contract costs998498
Less: Adjustments to total revenues:Reinsurance activity33147
Less: Adjustments to total revenues:Consolidated collateralized financing entities23
Less: Adjustments to total revenues:Other-3-16
Less: Adjustments to total revenues:Divested businesses3
Less: Adjustments to total revenues:Total adjusted revenues19,07517,921
Less: Adjustments to total revenues:Total expenses18,11916,360
Less: Adjustments to total expenses:Market risk benefit remeasurement (gains) losses-270-277
Less: Adjustments to total expenses:Asymmetrical and non-economic accounting22731
Less: Adjustments to total expenses:Market volatility-86-40
Less: Adjustments to total expenses:Unit-linked contract costs992486
Less: Adjustments to total expenses:Reinsurance activity20145
Less: Adjustments to total expenses:Consolidated collateralized financing entities19
Less: Adjustments to total expenses:Other4821
Less: Adjustments to total expenses:Divested businesses76
Less: Adjustments to total expenses:Total adjusted expenses16,98116,088

Balance Sheet

June 30, 2026

RIS – FUTURE POLICY BENEFITS (1) – June 30, 2025RIS – FUTURE POLICY BENEFITS (1) – September 30, 2025RIS – FUTURE POLICY BENEFITS (1) – December 31, 2025RIS – FUTURE POLICY BENEFITS (1) – March 31, 2026RIS – FUTURE POLICY BENEFITS (1) – June 30, 2026
Balance, end of period (at balance sheet discount rate) (2)73,50674,26384,98884,30084,563
Less: Accumulated other comprehensive (income) loss-2,366-1,209-1,732-2,968-2,505
Balance, end of period (at original discount rate)75,87275,47286,72087,26887,068
Future policyholder benefits subject to reinsurance (at balance sheet discount rate) (2)2,2667,75012,78612,50312,377
Add: Accumulated other comprehensive (income) loss-27-149-6311667
Balance, end of period (at original discount rate)2,2397,60112,72312,61912,444
POLICYHOLDER ACCOUNT BALANCESUnaudited (In millions)June 30, 2025September 30, 2025December 31, 2025March 31, 2026June 30, 2026
POLICYHOLDER ACCOUNT BALANCESBalance, end of period92,19792,29193,54996,11599,283
POLICYHOLDER ACCOUNT BALANCESPolicyholder account balances subject to reinsurance3,3274,2974,5715,131
FUTURE POLICY BENEFITS AND POLICYHOLDER ACCOUNT BALANCES GENERAL ACCOUNT RETAINED BALANCES (3)Unaudited (In millions)June 30, 2025September 30, 2025December 31, 2025March 31, 2026June 30, 2026
FUTURE POLICY BENEFITS AND POLICYHOLDER ACCOUNT BALANCES GENERAL ACCOUNT RETAINED BALANCES (3)Balance, end of period165,830156,835163,249166,193168,776

Balance Sheet

Three Months Ended June 30, 2026 — METLIFE INVESTMENT MANAGEMENT (in millions)

Three Months Ended June 30, 2026Three Months Ended June 30, 2025Change
Adjusted earnings57546.0%
Other revenues31723734.0%
Total assets under management748,126624,28720.0%
Full release

Forward-Looking Statements

This news release may contain or incorporate by reference information that includes or is based upon forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

Forward-looking statements give expectations or forecasts of future events and do not relate strictly to historical or current facts. They use words and terms such as “anticipate,” “are confident,” “assume,”

“believe,” “continue,” “could,” “estimate,” “expect,” “if,” “intend,” “likely,” “may,” “plan,” “potential,” “project,”

“should,” “target,” “will,” “would,” and other words and terms of similar meaning or that are otherwise tied to future periods or future performance, in each case in all derivative forms. They include statements relating to strategy, goals and expectations concerning our market position, future operations, margins, profitability, capital expenditures, liquidity and capital resources and other financial and operating information. By their nature, forward-looking statements: speak only as of the date they are made; are not statements of historical fact or guarantees of future performance; and are subject to risks, uncertainties, assumptions or changes in circumstances that are difficult to predict or quantify. Our expectations, beliefs and projections are expressed in good faith and we believe there is a reasonable basis for them.

However, there can be no assurance that management’s expectations, beliefs and projections will result or be achieved and actual results may vary materially from what is expressed in or indicated by the forward-looking statements.

Many factors determine the results of MetLife, Inc., its subsidiaries and affiliates, and they involve unpredictable risks and uncertainties. Our forward-looking statements depend on our assumptions, our expectations, and our understanding of the economic environment, but they may be inaccurate and may change. MetLife, Inc. does not guarantee any future performance. Our results could differ materially from those MetLife, Inc. expresses or implies in forward-looking statements. The risks, uncertainties and other factors identified in MetLife, Inc.’s filings with the U.S. Securities and Exchange Commission, and others, may cause such differences. These factors include:

(1) economic condition difficulties, including risks relating to interest rates, the effects of announced or future tariff increases on the global economy, credit spreads, declining equity or debt markets, changes in the value of assets under management, real estate, obligors and counterparties, government default or shutdown, currency exchange rates, derivatives, climate change, public health, terrorism and security;

(2) global capital and credit market adversity;

(3) credit facility inaccessibility;

(4) financial strength or credit ratings downgrades;

(5) unavailability, unaffordability, or inadequate reinsurance, including reinsurance risks that arise from reinsurers’ credit risk, and the potential shortfall or failure of risk mitigants to protect against such risks;

(6) statutory life insurance reserve financing costs or limited market capacity;

(7) legal, regulatory, and supervisory and enforcement policy changes;

(8) changes in tax rates, tax laws or interpretations;

(9) litigation and regulatory investigations;

(10) unsuccessful efforts to meet all sustainability standards or to enhance our sustainability;

(11)

MetLife, Inc.’s inability to pay dividends and repurchase common stock;

(12)... fe, Inc.’s subsidiaries’ inability to pay dividends to MetLife, Inc.;

(13) investment defaults, downgrades, or volatility;

(14) investment sales or lending difficulties;

Page 16 of 25

(15) collateral or derivative-related payments;

(16) investment valuations, allowances, or impairments changes;

(17) claims or other results that differ from our estimates, assumptions, or models;

(18) global political, legal, or operational risks;

(19) business competition;

(20) technological changes;

(21) catastrophes;

(22) climate changes or responses to it;

(23) deficiencies in our closed block;

(24) goodwill or other asset impairment, or deferred income tax asset allowance;

(25) impairment of value of business acquired ("VOBA"), value of distribution agreements acquired or value of customer relationships acquired;

(26) product guarantee volatility, costs, and counterparty risks;

(27) risk management failures;

(28) insufficient protection from operational risks;

(29) failure to protect confidentiality, integrity or availability of systems or data or other cybersecurity or disaster recovery failures;

(30) accounting standards changes;

(31) excessive risk-taking;

(32) marketing and distribution difficulties;

(33) pension and other postretirement benefit assumption changes;

(34) inability to protect our intellectual property or avoid infringement claims;

(35) acquisition, integration, growth, disposition, or reorganization difficulties;

(36)

Brighthouse Financial, Inc. separation risks;

(37)

MetLife, Inc.’s Board of Directors influence over the outcome of stockholder votes through the voting provisions of the MetLife Policyholder Trust; and

(38) legal- and corporate governance-related effects on business combinations.

MetLife, Inc. does not undertake any obligation to publicly correct or update any forward-looking statement if MetLife, Inc. later becomes aware that such statement is not likely to be achieved. Please consult any further disclosures MetLife, Inc. makes on related subjects in subsequent reports to the U.S.

Securities and

Exchange Commissi on.

Corporate Information

MetLife, Inc. encourage investors and others to frequently visit its website (www.metlife.com), including its

Investor Relations web pages (https://investor.metlife.com). MetLife announces significant financial and other information to its investors and the public on the Investor Relations web pages, as well as in U.S.

Securities and Exchange Commission filings, news releases, public conference calls and webcasts, fact sheets, social media posts, including of its senior executives, and other documents and media. The information found on MetLife’s website, including MetLife’s Sustainability Report, is not incorporated by reference into this earnings release or in any other report or document MetLife submits to the U.S.

Securities and Exchange Commission, and any references to its website are intended to be inactive textual references only.

Page 17 of 25

Page 18 of 25

Page 19 of 25

Page 20 of 25

Page 21 of 25

Page 22 of 25

Page 23 of 25

Page 24 of 25

Page 25 of 25

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Metlife earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.